Sintx Technologies, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $14.5M
- Price
- $2.17
- % Change (Daily % change from the live per-ticker quote feed.)
- -0.46%
- Volume
- 40.9K
About
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
Quick stats
Shares outstanding6.7M
Computed float6.2M
Float / shares93.1%
Cash runway (months)0.8
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001269026
Websitehttps://www.sintx.com
AI Summary
AI-generated1/16
majorbullishearnings
SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance
SINTX announced preliminary unaudited Q3 revenue of $2.2 million, more than doubling the high end of its $0.9-$1.1 million guidance on stronger-than-expected industrial ceramics sales to Fortune 500 aerospace subsidiaries.
The quarter's revenue represents roughly 380% growth from Q2 and more than ten times the prior-year quarter, with ~$2.1 million from product sales surpassing the $2.0 million Call Right trigger for the Class B Warrants covering about 1.88 million shares.
If fully exercised at market-based prices, the warrant call could deliver up to $4.0 million in additional capital, though proceeds are not assured; Q4 guidance was reiterated.
Red flags
- Q3 revenue figure is preliminary, unaudited, and subject to material adjustment
- Warrant call introduces potential dilution of ~1.88 million shares; exercise proceeds not assured
- Micro-cap with narrow revenue base; majority of quarter driven by a few Fortune 500 aerospace customer orders